CDH16 and oncocytic adenoma: They described CDH16 positivity in 0% to 95% of 6–41 analyzed oncocytomas 10–14,17, 5.6% to 100% of 7–36 chromophobe RCCs10–15,17, 0% to 29% of 14–46 papillary RCCs10–13,16, and 0% to 30% of 15–102 clear cell RCCs10–15.